Genfit Stock

Genfit Gross Margin

The Gross Margin of Genfit (GNFT.PA) as of Aug 10, 2026 is 97.11 %. In the previous year, Gross Margin was 94.32 % — a change of 2.96% (higher).

Gross Margin

97.11 %

YoY

2.96%

Last updated:

Gross Margin of Genfit is 2026 97.11 % . Gross Margin of Genfit was 2025 94.32 % . It decreases by 2.96% higher compared to the previous year.

For Genfit, the gross margin of 97.1% is up versus 73.2% a few years ago.

Access this data via the Eulerpool API

Genfit Stock analysis

What does Genfit do? Genfit SA is a French company specializing in the development of therapies for the treatment of liver diseases, specifically non-alcoholic steatohepatitis (NASH). The company was founded in 1999 and is headquartered in Loos, France. Genfit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genfit stock

Gross Margin of Genfit is 97.11 % in 2026.

Gross Margin of Genfit changed from 94.32 % to 97.11 %, representing a 2.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Genfit since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Genfit with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Genfit

All Key Metrics — Genfit